Table 3 Gender- and BMI-stratified ORs and 95% CIs for IBS across tertiles of dTAC
| Â | Tertiles of dTAC | Ptrend | ||
|---|---|---|---|---|
T1 (< 6.06) | T2 (6.06–8.96) | T3 (> 8.96) | ||
OR | OR (95% CI) | OR (95% CI) | ||
Whole population | ||||
 Crude | 1.00 | 0.98 (0.80–1.19) | 0.92 (0.75–1.12) | 0.41 |
 Model 1a | 1.00 | 1.08 (0.87–1.36) | 1.12 (0.88–1.44) | 0.35 |
 Model 2 | 1.00 | 1.11 (0.88–1.39) | 1.11 (0.86–1.43) | 0.43 |
 Model 3 | 1.00 | 1.15 (0.90–1.46) | 1.12 (0.86–1.46) | 0.42 |
 Model 4 | 1.00 | 1.09 (0.85–1.39) | 1.07 (0.81–1.40) | 0.64 |
Male | ||||
 Crude | 1.00 | 1.01 (0.73–1.39) | 0.94 (0.67–1.31) | 0.73 |
 Model 1b | 1.00 | 1.33 (0.90–1.97) | 1.40 (0.91–2.15) | 0.13 |
 Model 2 | 1.00 | 1.28 (0.86–1.91) | 1.31 (0.85–2.03) | 0.23 |
 Model 3 | 1.00 | 1.56 (1.02–2.39) | 1.52 (0.95–2.43) | 0.09 |
 Model 4 | 1.00 | 1.47 (0.95–2.27) | 1.39 (0.86–2.24) | 0.21 |
Female | ||||
 Crude | 1.00 | 0.97 (0.75–1.24) | 0.90 (0.75–1.24) | 0.39 |
 Model 1b | 1.00 | 0.99 (0.75–1.30) | 1.01 (0.75–1.37) | 0.94 |
 Model 2 | 1.00 | 1.03 (0.78–1.36) | 1.01 (0.74–1.38) | 0.95 |
 Model 3 | 1.00 | 1.01 (0.75–1.35) | 0.96 (0.69–1.34) | 0.83 |
 Model 4 | 1.00 | 0.96 (0.71–1.29) | 0.95 (0.68–1.32) | 0.77 |
BMI < 25 (kg/m2) | ||||
 Crude | 1.00 | 1.09 (0.83–1.42) | 0.80 (0.60–1.42) | 0.13 |
 Model 1a | 1.00 | 1.19 (0.87–1.62) | 1.02 (0.72–1.44) | 0.91 |
 Model 2 | 1.00 | 1.21 (0.88–1.66) | 1.01 (0.71–1.43) | 1.00 |
 Model 3 | 1.00 | 1.19 (0.85–1.66) | 1.00 (0.69–1.45) | 0.97 |
BMI ≥ 25 (kg/m2) | ||||
 Crude | 1.00 | 0.90 (0.66–1.23) | 1.05(0.77–1.42) | 0.75 |
 Model 1a | 1.00 | 1.04 (0.73–1.47) | 1.25 (0.85–1.83) | 0.25 |
 Model 2 | 1.00 | 1.03 (0.72–1.47) | 1.21 (0.82–1.79) | 0.33 |
 Model 3 | 1.00 | 1.13 (0.78–1.63) | 1.25 (0.82–1.88) | 0.30 |